Literature DB >> 28203443

Could Sox2 be a useful target to treat lung squamous cell carcinoma?

Juan-Jose Ventura1.   

Abstract

Entities:  

Year:  2017        PMID： 28203443      PMCID： PMC5303091          DOI： 10.21037/jtd.2017.01.37

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  8 in total

Review 1.  Pathology of lung cancer.

Authors:  William D Travis
Journal:  Clin Chest Med       Date:  2002-03       Impact factor: 2.878

2.  Cancer statistics, 2015.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-01-05       Impact factor: 508.702

3.  SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma.

Authors:  Takuya Fukazawa; Minzhe Guo; Naomasa Ishida; Tomoki Yamatsuji; Munenori Takaoka; Etsuko Yokota; Minoru Haisa; Noriko Miyake; Tomoko Ikeda; Tatsuo Okui; Nagio Takigawa; Yutaka Maeda; Yoshio Naomoto
Journal:  Sci Rep       Date:  2016-02-05       Impact factor: 4.379

4.  SOX2 Is the Determining Oncogenic Switch in Promoting Lung Squamous Cell Carcinoma from Different Cells of Origin.

Authors:  Giustina Ferone; Ji-Ying Song; Kate D Sutherland; Rajith Bhaskaran; Kim Monkhorst; Jan-Paul Lambooij; Natalie Proost; Gaetano Gargiulo; Anton Berns
Journal:  Cancer Cell       Date:  2016-10-10       Impact factor: 31.743

5.  Overexpression of SOX2 Is Associated with Better Overall Survival in Squamous Cell Lung Cancer Patients Treated with Adjuvant Radiotherapy.

Authors:  Hong In Yoon; Kyu Hyun Park; Eun-Jung Lee; Ki Chang Keum; Chang Geol Lee; Chul Hoon Kim; Yong Bae Kim
Journal:  Cancer Res Treat       Date:  2015-08-12       Impact factor: 4.679

6.  SOX2 expression is associated with FGFR fusion genes and predicts favorable outcome in lung squamous cell carcinomas.

Authors:  Shanbo Zheng; Yunjian Pan; Rui Wang; Yuan Li; Chao Cheng; Xuxia Shen; Bin Li; Difan Zheng; Yihua Sun; Haiquan Chen
Journal:  Onco Targets Ther       Date:  2015-10-19       Impact factor: 4.147

7.  Genetic alteration profiling of patients with resected squamous cell lung carcinomas.

Authors:  Dan Tao; Xiaohong Han; Ningning Zhang; Dongmei Lin; Di Wu; Xinxin Zhu; Wenya Song; Yuankai Shi
Journal:  Oncotarget       Date:  2016-06-14

8.  Prognostic significance of stem cell-related marker expression and its correlation with histologic subtypes in lung adenocarcinoma.

Authors:  Eunhyang Park; Soo Young Park; Ping-Li Sun; Yan Jin; Ji Eun Kim; Sanghoon Jheon; Kwhanmien Kim; Choon Taek Lee; Hyojin Kim; Jin-Haeng Chung
Journal:  Oncotarget       Date:  2016-07-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.